Related Experiment Video
Updated: Jul 15, 2026
09:04
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
[Transplacental effects of bemithyl]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|April 4, 2007
Summary
Bemithyl administration during pregnancy reduced fetal death and increased fetal weight in rats. Offspring also showed improved physical development and reflexes post-birth.
Area of Science:
- Pharmacology and Toxicology
- Developmental Biology
- Reproductive Science
Context:
- Investigating the effects of xenobiotics on prenatal and postnatal development.
- Assessing the impact of maternal treatment on fetal viability and growth.
- Evaluating the long-term effects on offspring neurodevelopment and physical maturation.
Purpose:
- To determine the efficacy of bemithyl in mitigating fetal loss and enhancing fetal growth.
- To examine the influence of bemithyl on the developmental trajectory of progeny.
- To assess the impact on the maturation of physical condition and sensomotor reflexes.
Summary:
- Daily bemithyl administration (20 mg/kg) from gestational day 6 to 16 in female rats.
- Observed a significant decrease in post-implantation fetal death and increased fetal body weight.
- Progeny exhibited accelerated development of physical condition and sensomotor reflexes in the postnatal period.
Impact:
- Bemithyl demonstrates potential as a protective agent during pregnancy, improving fetal outcomes.
- Suggests a positive influence on offspring development, potentially enhancing long-term health and capabilities.
- Highlights the importance of maternal health interventions for optimizing progeny development.
More Related Videos
05:31Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
08:08Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:25Physiological Barriers
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...